Interest of vaginal brachytherapy in intermediate-risk and high intermediate-risk of endometrial cancer on local recurrence: Results of a French Multicenter Study

Introduction: Endometrial cancer is the first pelvic gynecological cancer in terms of incidence in France and is represented in 80% by type 1 histological (endometrioid adenocarcinoma). In January 2016, The European Society of Medical Oncology, European Society of Gynaecological Oncology and European SocieTy of Radiotherapy and Oncology (ESMO-ESGO-ESTRO) published a new postoperative classification, based on definitive pathological analysis, aimed for adapting adjuvant management.
Source: European Journal of Obstetrics, Gynecology, and Reproductive Biology - Category: OBGYN Authors: Tags: Session 34 – Oncology and fertility preservation Source Type: research